Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Công thức hóa học
C11H16N2O8
Monoisotopic mass
304.090665498
InChI
InChI=1/C11H16N2O8/c1-5(14)12-7(11(20)21)4-8(15)13-6(10(18)19)2-3-9(16)17/h6-7H,2-4H2,1H3,(H,12,14)(H,13,15)(H,16,17)(H,18,19)(H,20,21)/t6-,7+/s2
InChI Key
InChIKey=GUCKKCMJTSNWCU-JHPDDGAFNA-N
IUPAC Name
(2R)-2-[(3S)-3-carboxy-3-acetamidopropanamido]pentanedioic acid
Traditional IUPAC Name
(2R)-2-[(3S)-3-carboxy-3-acetamidopropanamido]pentanedioic acid
SMILES
CC(=O)N[C@@H](CC(=O)N[C@H](CCC(O)=O)C(O)=O)C(O)=O
pKa (strongest acidic)
3.01
pKa (Strongest Basic)
-1.5
Refractivity
64.06 m3·mol-1
Cơ Chế Tác Dụng :
Spaglumic acid is the β-aspartyl isoform of N-Acetyl-l-aspartylglutamate (isospaglumic Acid is N-(N-Acetyl-l-α-aspartyl)-l-glutamic acid). In eye drops, spaglumic acid is either a magnesium or sodium salt of N-Acetyl-l-aspartylglutamate. Spaglumic acid is a mast cell stabilizer. Thus it is used in allergic conditions such as allergic conjunctivitis. Specifically spaglumic acid is approved in Portugal under the brand name Naabak and in Greece under the brand name Naaxia for use in patients with allergic conjunctivitis.
Spaglumic acid is a mast cell stabilizer. Mast cells are involved in producing an allergic response by releasing inflammatory mediators such as histamine. Mast cell stablizers block the release of histamine and other mediators by inhibiting mast cell degranulation, which is the process of releasing these mediators. Inhibition occurs through inhibition of specific calcium channels to stabilize the mast cell and prevent degranulation.
Chỉ Định :
Used in patients with allergic conjunctivitis.